Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Cerebrovascular Disorders

Free Subscription Articles published in Lancet Retrieve available abstracts of 59 articles: HTML format

Single Articles

December 2025
1. ANDERSON CS, Sui Y, Urrutia VC
   The importance of patient selection in stroke monitoring research - Authors' reply.
   Lancet. 2025;406:2756.
   PubMed    
   
   
   
2. HAYASHI S, Yasuda T, Shiraishi A
   The importance of patient selection in stroke monitoring research.
   Lancet. 2025;406:2755-2756.
   PubMed    
   
   
   October 2025
3. KIRBY T
   Xunming Ji: preventing and treating stroke in China.
   Lancet. 2025 Oct 27:S0140-6736(25)02176-2. doi: 10.1016/S0140-6736(25)02176.
   PubMed    
   
   
   
4. CACOUB P, Vieira M, Langford CA, Tazi Mezalek Z, et al
   Large-vessel vasculitis.
   Lancet. 2025;406:2017-2032.
   PubMed     Abstract available
   
   
   August 2025
5. CHENG SP, Chen PH, Jhou HJ
   Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
   Lancet. 2025;406:601.
   PubMed    
   
   
   
6. WERRING DJ, Dehbi HM, Best JG, Nash PS, et al
   Timing of cardiac surgery and anticoagulants after acute ischaemic stroke - Authors' reply.
   Lancet. 2025;406:601-602.
   PubMed    
   
   
   
7. POCAR M, Barbero C, Cerrato P, De Rosa FG, et al
   Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
   Lancet. 2025;406:600-601.
   PubMed    
   
   
   June 2025
8. ZIAI WC, Tsivgoulis G
   Timing of anticoagulation after ischaemic stroke and atrial fibrillation: better swift than sorry.
   Lancet. 2025 Jun 23:S0140-6736(25)00676-2. doi: 10.1016/S0140-6736(25)00676.
   PubMed    
   
   
   
9. DEHBI HM, Fischer U, Asberg S, Milling TJ, et al
   Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).
   Lancet. 2025 Jun 23:S0140-6736(25)00439-8. doi: 10.1016/S0140-6736(25)00439.
   PubMed     Abstract available
   
   
   May 2025
10. ASHCRAFT S
    Safety of low-intensity monitoring after thrombolysis in acute ischaemic stroke.
    Lancet. 2025;405:1884-1885.
    PubMed    
    
    
    
11. ANDERSON CS, Summers D, Ouyang M, Sui Y, et al
    Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferio
    Lancet. 2025 May 20:S0140-6736(25)00549-5. doi: 10.1016/S0140-6736(25)00549.
    PubMed     Abstract available
    
    
    
12. SONG L, Li Q, Anderson CS
    Traditional Chinese medicine for acute intracerebral haemorrhage - Authors' reply.
    Lancet. 2025;405:1741-1742.
    PubMed    
    
    
    
13. CHEN Y, Liang X, Liu Z
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1741.
    PubMed    
    
    
    
14. XU X, Fan H, Liu Q
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1740.
    PubMed    
    
    
    
15. ZHANG F, Wang Z, Kong W, Zhang W, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1739.
    PubMed    
    
    
    
16. ZHU Y, Hu J, Ji S, Huang M, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1739-1740.
    PubMed    
    
    
    
17. FAN AY, Gu S, Gong C
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1738.
    PubMed    
    
    
    
18. JIA H, Liu W, Fan X, Li Y, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1738-1739.
    PubMed    
    
    
    
19. LUO R, Hui H, Ge H, Ran X, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1737-1738.
    PubMed    
    
    
    March 2025
20. CHOI KH, Park YH, Lee JY, Jeong JO, et al
    Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00449-0. doi: 10.1016/S0140-6736(25)00449.
    PubMed     Abstract available
    
    
    February 2025
21. VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al
    Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333.
    PubMed     Abstract available
    
    
    
22. CHRISTENSON J, Hill MD, Swartz RH, Adams C, et al
    Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.
    Lancet. 2025;405:571-582.
    PubMed     Abstract available
    
    
    
23. HILL MD, Goyal M, Demchuk AM, Menon BK, et al
    Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2025;405:560-570.
    PubMed     Abstract available
    
    
    
24. KOOHI N, Simonyan S, Joffily L, Simister R, et al
    Testing hearing in suspected stroke: a diagnostic opportunity.
    Lancet. 2025;405:540-541.
    PubMed    
    
    
    
25. LI W, Lan J, Wei M, Liu L, et al
    Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial.
    Lancet. 2025;405:486-497.
    PubMed     Abstract available
    
    
    
26. DIPPEL DWJ, Janssen PM
    Effect of normobaric hyperoxia in ischaemic stroke.
    Lancet. 2025;405:442-443.
    PubMed    
    
    
    January 2025
27. FISCHER U, Butikofer L, Raabe A, Beck J, et al
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial - Authors' reply.
    Lancet. 2025;405:31-32.
    PubMed    
    
    
    
28. MARSCHNER IC
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:31.
    PubMed    
    
    
    
29. ENGRAND N, Miry L
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:30-31.
    PubMed    
    
    
    
30. FRONTERA JA, Morris NA
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:30.
    PubMed    
    
    
    
31. ROEPKE RML, Adler Maccagnan Pinheiro Besen B
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:29-30.
    PubMed    
    
    
    December 2024
32. HO JK, Hankey GJ
    Endovascular therapy for ischaemic stroke due to vertebrobasilar artery occlusion.
    Lancet. 2024 Dec 11:S0140-6736(24)02137-8. doi: 10.1016/S0140-6736(24)02137.
    PubMed    
    
    
    
33. NOGUEIRA RG, Jovin TG, Liu X, Hu W, et al
    Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis.
    Lancet. 2024 Dec 11:S0140-6736(24)01820-8. doi: 10.1016/S0140-6736(24)01820.
    PubMed     Abstract available
    
    
    November 2024
34. DHILLON PS, Nguyen TN
    Temporary blood flow arrest during endovascular thrombectomy for acute ischaemic stroke.
    Lancet. 2024 Nov 20:S0140-6736(24)02461-9. doi: 10.1016/S0140-6736(24)02461.
    PubMed    
    
    
    
35. LIU J, Zhou Y, Zhang L, Li Z, et al
    Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet. 2024 Nov 20:S0140-6736(24)02315-8. doi: 10.1016/S0140-6736(24)02315.
    PubMed     Abstract available
    
    
    
36. WU S
    Integrative medicine for the treatment of stroke.
    Lancet. 2024 Nov 12:S0140-6736(24)02257-8. doi: 10.1016/S0140-6736(24)02257.
    PubMed    
    
    
    
37. GUO J, Chen X, Wu M, Wang D, et al
    Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial.
    Lancet. 2024 Nov 12:S0140-6736(24)02261-X. doi: 10.1016/S0140-6736(24)02261.
    PubMed     Abstract available
    
    
    
38. WOLF ME, Roser E, Bazner H
    Embolic stroke and patent foramen ovale in a 43-year-old fan chanting during a football match.
    Lancet. 2024;404:1760.
    PubMed    
    
    
    
39. THOMALLA G, Bonekamp S, Fiehler J, Bendszus M, et al
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial - Authors' reply.
    Lancet. 2024;404:1729-1730.
    PubMed    
    
    
    
40. JHOU HJ, Yang LY, Chen PH
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728.
    PubMed    
    
    
    
41. WANG Z, Huang K, Huang ZX
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728-1729.
    PubMed    
    
    
    
42. BROOCKS G, Kemmling A
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1727-1728.
    PubMed    
    
    
    October 2024
43. WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al
    Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
    Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197.
    PubMed     Abstract available
    
    
    
44. SANDSET EC, de Sousa DA
    Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation.
    Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259.
    PubMed    
    
    
    September 2024
45. NGUYEN TN, Abdalkader M, Fischer U, Qiu Z, et al
    Endovascular management of acute stroke.
    Lancet. 2024;404:1265-1278.
    PubMed     Abstract available
    
    
    
46. PREVEL R, Boyer A, Gruson D, Orieux A, et al
    Catheter ablation for atrial fibrillation, atrio-oesophageal fistula, cerebral air embolism, and hyperbaric oxygen therapy.
    Lancet. 2024;404:1051-1052.
    PubMed    
    
    
    August 2024
47. CASADO-NARANJO I, Portilla-Cuenca JC, Duarte-Martin JJ, Moyano-Calvente SL, et al
    Multiple intracerebral haemorrhages and ubiquitous brain microbleeds in a patient with Down syndrome: cerebral amyloid angiopathy.
    Lancet. 2024;404:e4.
    PubMed    
    
    
    
48. JAVED S, Zaidi DA, Yaqoob E
    Addressing the deficiencies in stroke care in Pakistan.
    Lancet. 2024;404:651-652.
    PubMed    
    
    
    June 2024
49. RAJ R, Tommiska P, Koivisto T, Leinonen V, et al
    Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trial.
    Lancet. 2024;403:2798-2806.
    PubMed     Abstract available
    
    
    
50. SHIBAHASHI K
    Optimising treatment for chronic subdural haematoma.
    Lancet. 2024;403:2757-2759.
    PubMed    
    
    
    
51. LIU J, Li Y, Ge J, Yan X, et al
    Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
    Lancet. 2024 Jun 27:S0140-6736(24)01028-6. doi: 10.1016/S0140-6736(24)01028.
    PubMed     Abstract available
    
    
    
52. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed     Abstract available
    
    
    
53. KATSANOS AH, Shoamanesh A
    Colchicine for the prevention of vascular events after non-cardioembolic stroke.
    Lancet. 2024 Jun 7:S0140-6736(24)01096-1. doi: 10.1016/S0140-6736(24)01096.
    PubMed    
    
    
    May 2024
54. COUTTS SB, Ankolekar S, Appireddy R, Arenillas JF, et al
    Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
    Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921.
    PubMed     Abstract available
    
    
    
55. SACCO S, Turc G
    Advances and challenges in the acute treatment of minor ischaemic stroke.
    Lancet. 2024 May 16:S0140-6736(24)00981-4. doi: 10.1016/S0140-6736(24)00981.
    PubMed    
    
    
    
56. HILKENS NA, Casolla B, Leung TW, de Leeuw FE, et al
    Stroke.
    Lancet. 2024 May 14:S0140-6736(24)00642-1. doi: 10.1016/S0140-6736(24)00642.
    PubMed     Abstract available
    
    
    
57. BECK J, Fung C, Strbian D, Butikofer L, et al
    Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial.
    Lancet. 2024 May 14:S0140-6736(24)00702-5. doi: 10.1016/S0140-6736(24)00702.
    PubMed     Abstract available
    
    
    
58. KLIJN CJ, Dammers R, Sprigg N
    Decompressive craniectomy for deep intracerebral haemorrhage: a SWITCH towards better outcomes?
    Lancet. 2024 May 14:S0140-6736(24)00703-7. doi: 10.1016/S0140-6736(24)00703.
    PubMed    
    
    
    March 2024
59. MELLO A, Stehr D, Bujarski K, Duchaine B, et al
    Visualising facial distortions in prosopometamorphopsia.
    Lancet. 2024;403:1176.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cerebrovascular Disorders is free of charge.